Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
9.56
+0.11 (1.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Astria Therapeutics Employees
Astria Therapeutics had 59 employees as of December 31, 2023. The number of employees increased by 17 or 40.48% compared to the previous year.
Employees
59
Change (1Y)
17
Growth (1Y)
40.48%
Revenue / Employee
n/a
Profits / Employee
-$1,695,661
Market Cap
539.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pacific Biosciences of California | 796 |
Phathom Pharmaceuticals | 452 |
SI-BONE | 344 |
OrthoPediatrics | 247 |
ORIC Pharmaceuticals | 100 |
CorMedix | 83 |
Terns Pharmaceuticals | 66 |
Mind Medicine (MindMed) | 57 |
ATXS News
- 10 days ago - Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE - Business Wire
- 11 days ago - Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis - Business Wire
- 18 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Astria Therapeutics: Transformative Proof Of Concept Data In Hereditary Angioedema - Seeking Alpha
- 5 weeks ago - Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire
- 5 weeks ago - Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference - Business Wire
- 7 weeks ago - Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - Business Wire